annual cash & cash equivalents:
$2.89B-$19.60M(-0.67%)Summary
- As of today (June 22, 2025), CME annual cash & cash equivalents is $2.89 billion, with the most recent change of -$19.60 million (-0.67%) on December 31, 2024.
- During the last 3 years, CME annual cash & cash equivalents has risen by +$57.50 million (+2.03%).
- CME annual cash & cash equivalents is now -0.67% below its all-time high of $2.91 billion, reached on December 31, 2023.
Performance
CME Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.41B-$1.49B(-51.41%)Summary
- As of today (June 22, 2025), CME quarterly cash & cash equivalents is $1.41 billion, with the most recent change of -$1.49 billion (-51.41%) on March 31, 2025.
- Over the past year, CME quarterly cash & cash equivalents has dropped by -$31.60 million (-2.20%).
- CME quarterly cash & cash equivalents is now -51.74% below its all-time high of $2.91 billion, reached on December 31, 2023.
Performance
CME quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CME Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | -2.2% |
| 3 y3 years | +2.0% | -31.3% |
| 5 y5 years | +86.4% | +65.0% |
CME Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +6.3% | -51.7% | at low |
| 5 y | 5-year | -0.7% | +86.4% | -51.7% | +65.0% |
| alltime | all time | -0.7% | +9335.3% | -51.7% | +2821.3% |
CME Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.41B(-51.4%) |
| Dec 2024 | $2.89B(-0.7%) | $2.89B(+24.6%) |
| Sep 2024 | - | $2.32B(+29.7%) |
| Jun 2024 | - | $1.79B(+24.6%) |
| Mar 2024 | - | $1.44B(-50.7%) |
| Dec 2023 | $2.91B(+7.1%) | $2.91B(+26.6%) |
| Sep 2023 | - | $2.30B(+22.3%) |
| Jun 2023 | - | $1.88B(+20.1%) |
| Mar 2023 | - | $1.57B(-42.5%) |
| Dec 2022 | $2.72B(-4.0%) | $2.72B(+27.7%) |
| Sep 2022 | - | $2.13B(+13.3%) |
| Jun 2022 | - | $1.88B(-8.1%) |
| Mar 2022 | - | $2.05B(-27.8%) |
| Dec 2021 | $2.83B(+73.6%) | $2.83B(+94.3%) |
| Sep 2021 | - | $1.46B(+35.0%) |
| Jun 2021 | - | $1.08B(+15.4%) |
| Mar 2021 | - | $936.40M(-42.7%) |
| Dec 2020 | $1.63B(+5.3%) | $1.63B(+22.6%) |
| Sep 2020 | - | $1.33B(-5.2%) |
| Jun 2020 | - | $1.41B(+65.0%) |
| Mar 2020 | - | $851.70M(-45.1%) |
| Dec 2019 | $1.55B(+12.9%) | $1.55B(+28.2%) |
| Sep 2019 | - | $1.21B(+29.0%) |
| Jun 2019 | - | $937.70M(-6.0%) |
| Mar 2019 | - | $997.40M(-27.4%) |
| Dec 2018 | $1.37B(-27.8%) | $1.37B(-2.3%) |
| Sep 2018 | - | $1.41B(+28.0%) |
| Jun 2018 | - | $1.10B(+40.1%) |
| Mar 2018 | - | $784.60M(-58.8%) |
| Dec 2017 | $1.90B(+1.9%) | $1.90B(+16.7%) |
| Sep 2017 | - | $1.63B(+19.7%) |
| Jun 2017 | - | $1.36B(+5.8%) |
| Mar 2017 | - | $1.29B(-31.1%) |
| Dec 2016 | $1.87B(+10.4%) | $1.87B(+31.5%) |
| Sep 2016 | - | $1.42B(+22.3%) |
| Jun 2016 | - | $1.16B(+1.3%) |
| Mar 2016 | - | $1.15B(-32.3%) |
| Dec 2015 | $1.69B(+23.9%) | $1.69B(+18.0%) |
| Sep 2015 | - | $1.43B(+24.6%) |
| Jun 2015 | - | $1.15B(-32.1%) |
| Mar 2015 | - | $1.69B(+24.1%) |
| Dec 2014 | $1.37B(-44.7%) | $1.37B(+25.6%) |
| Sep 2014 | - | $1.09B(+4.9%) |
| Jun 2014 | - | $1.04B(-1.6%) |
| Mar 2014 | - | $1.05B(-57.3%) |
| Dec 2013 | $2.47B | $2.47B(+19.6%) |
| Sep 2013 | - | $2.06B(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $1.97B(+6.8%) |
| Mar 2013 | - | $1.84B(+14.9%) |
| Dec 2012 | $1.60B(+54.0%) | $1.60B(-20.4%) |
| Sep 2012 | - | $2.02B(+56.0%) |
| Jun 2012 | - | $1.29B(+21.8%) |
| Mar 2012 | - | $1.06B(+1.9%) |
| Dec 2011 | $1.04B(+21.9%) | $1.04B(+25.7%) |
| Sep 2011 | - | $829.30M(+19.6%) |
| Jun 2011 | - | $693.60M(+4.3%) |
| Mar 2011 | - | $664.70M(-22.3%) |
| Dec 2010 | $855.20M(+228.2%) | $855.20M(+50.5%) |
| Sep 2010 | - | $568.20M(+56.3%) |
| Jun 2010 | - | $363.60M(-18.1%) |
| Mar 2010 | - | $444.20M(+70.5%) |
| Dec 2009 | $260.60M(-12.5%) | $260.60M(+27.7%) |
| Sep 2009 | - | $204.10M(-54.5%) |
| Jun 2009 | - | $448.70M(+32.3%) |
| Mar 2009 | - | $339.20M(+13.9%) |
| Dec 2008 | $297.90M(-64.8%) | $297.90M(-48.9%) |
| Sep 2008 | - | $582.42M(-45.4%) |
| Jun 2008 | - | $1.07B(+0.1%) |
| Mar 2008 | - | $1.07B(+26.1%) |
| Dec 2007 | $845.31M(-12.8%) | $845.31M(+24.9%) |
| Sep 2007 | - | $677.03M(-42.4%) |
| Jun 2007 | - | $1.17B(+3.1%) |
| Mar 2007 | - | $1.14B(+17.6%) |
| Dec 2006 | $969.50M(+58.7%) | $969.50M(+11.6%) |
| Sep 2006 | - | $868.62M(+11.1%) |
| Jun 2006 | - | $782.14M(+9.3%) |
| Mar 2006 | - | $715.68M(+17.2%) |
| Dec 2005 | $610.89M(+70.8%) | $610.89M(+4.3%) |
| Sep 2005 | - | $585.66M(+17.4%) |
| Jun 2005 | - | $498.97M(+15.9%) |
| Mar 2005 | - | $430.62M(+20.4%) |
| Dec 2004 | $357.56M(+93.1%) | $357.56M(+26.4%) |
| Sep 2004 | - | $282.78M(+27.2%) |
| Jun 2004 | - | $222.34M(+18.3%) |
| Mar 2004 | - | $187.99M(+1.5%) |
| Dec 2003 | $185.12M(-45.4%) | $185.12M(-52.7%) |
| Sep 2003 | - | $391.53M(-0.3%) |
| Jun 2003 | - | $392.83M(+10.1%) |
| Mar 2003 | - | $356.95M(+5.2%) |
| Dec 2002 | $339.26M(+391.0%) | $339.26M(+72.1%) |
| Sep 2002 | - | $197.16M(+309.9%) |
| Jun 2002 | - | $48.11M(-27.0%) |
| Mar 2002 | - | $65.90M(-4.6%) |
| Dec 2001 | $69.10M(+125.4%) | $69.10M |
| Dec 2000 | $30.66M | - |
FAQ
- What is CME annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CME?
- What is CME annual cash & cash equivalents year-on-year change?
- What is CME quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for CME?
- What is CME quarterly cash & cash equivalents year-on-year change?
What is CME annual cash & cash equivalents?
The current annual cash & cash equivalents of CME is $2.89B
What is the all time high annual cash & cash equivalents for CME?
CME all-time high annual cash & cash equivalents is $2.91B
What is CME annual cash & cash equivalents year-on-year change?
Over the past year, CME annual cash & cash equivalents has changed by -$19.60M (-0.67%)
What is CME quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CME is $1.41B
What is the all time high quarterly cash & cash equivalents for CME?
CME all-time high quarterly cash & cash equivalents is $2.91B
What is CME quarterly cash & cash equivalents year-on-year change?
Over the past year, CME quarterly cash & cash equivalents has changed by -$31.60M (-2.20%)